$Viracta Therapeutics (VIRX.US)$ Oppenheimer analyst Hartaj ...

zine1 commented on a stock · Apr 17 09:34

$Viracta Therapeutics(VIRX.US)$ Oppenheimer analyst Hartaj Singh maintains Viracta Therapeutics (NASDAQ:VIRX) with a Outperform and maintains $13 price target.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

2300 Views

Comment

zine1

160Followers

7Following

1074Visitors